TroZonX17 uses funding from LifeArc to advance rapid testing for Chagas disease.
Chagas disease is a debilitating and fatal parasitic disease that impacts over 6 million people in Latin America. Despite advances in...
top of page
Latest News
Search
barrierooney
Nov 11, 20203 min read
Biomarker Development brings promise of greater access to Chagas Disease diagnosis
Chagas Disease affects about 6–8 million people worldwide1 but less than 1% of the cases are diagnosed . A new study appearing in the...
barrierooney
Nov 11, 20201 min read
Imperial College London covers our latest publication
Imperial College London has written about our latest publication in Scientific Reports. Reporter Hayley Dunning has written up our...
barrierooney
Oct 2, 20201 min read
Glycosylation of Trypanosoma cruzi TcI antigen reveals recognition by chagasic sera
Glycosylation of Trypanosoma cruzi TcI antigen reveals recognition by chagasic sera
bottom of page